Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Chemomab Therapeutics Ltd ADR (CMMB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2024	12-2023	12-2022	12-2021	12-2020
Assets
Current Assets
Cash & Cash Equivalents	6,147	9,368	13,596	15,186	11,674
Marketable Securities	8,195	10,492	26,374	45,975	24
Receivables	1,698	1,037	1,766	N/A	141
TOTAL	$16,040	$20,897	$41,736	$62,688	$11,839

Non-Current Assets
PPE Net	250	303	367	357	152
Other Non-Current Assets	674	951	960	1,308	485
TOTAL	$924	$1,254	$1,327	$1,665	$637

Total Assets	$16,964	$22,151	$43,063	$64,353	$12,476

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	666	516	1,688	1,336	93
Accrued Expenses	1,563	3,423	3,378	555	715
Other current liabilities	874	823	1,560	653	438
TOTAL	$3,218	$4,838	$6,749	$2,650	$1,316

Non-Current Liabilities
Other Non-Current Liabilities	209	316	91	237	358
TOTAL	$209	$316	$91	$237	$358

Total Liabilities	$3,427	$5,154	$6,840	$2,887	$1,674

Shareholders' Equity
Shares Outstanding, K	N/A	3,551	2,762	2,851	11,594
Retained earnings	-102,623	-88,678	-63,819	-36,173	-23,695
Other shareholders' equity	0	0	-218	0	0
TOTAL	$13,537	$16,997	$36,223	$61,466	$10,802

Total Liabilities And Equity	$16,964	$22,151	$43,063	$64,353	$12,476